Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
12/2005
12/28/2005EP1245561B1 N-substituted benzyl or phenyl aromatic sulfamides compounds and the use thereof
12/28/2005EP1235565B1 Use of 5ht 3 agonists for relaxing the fundus
12/28/2005EP1234581B1 Use of secretory leucocyte protease inhibitor for keloid and scars
12/28/2005EP1224183B1 Heterocyclic sodium/proton exchange inhibitors and method
12/28/2005EP1223170B1 Pyrimidine-5-carboxamide compounds, process for producing the same and use thereof
12/28/2005EP1207807A4 Method for inducing hypothermia
12/28/2005EP1129089B1 Spiro-indolines as y5 receptor antagonists
12/28/2005EP1124810B9 2-amino-thiazole derivatives, process for their preparation, and their use as antitumor agents
12/28/2005EP1084125B1 Condensed thienopyrimidines with phosphodiesterase-v inhibiting action
12/28/2005EP1082128B1 Lysine containing peptides for treatment of heart disease
12/28/2005EP1066033B1 Smilagenin and anzurogenin-d for the treatment of alzheimer's disease
12/28/2005EP1025227B1 Human toll homologues
12/28/2005EP0778836B1 Substituted 9-alkyladenines
12/28/2005EP0716609B1 Methods and compositions for stimulating and inhibiting tgf-beta activity
12/28/2005EP0705103B1 Use of notoginsenoside r1 for the treatment of endotoxin shock or heart diseases
12/28/2005CN1714151A Novel glutamate receptor modulatory proteins and nucleic acid molecules and uses therefor
12/28/2005CN1714096A Mmp inhibitors
12/28/2005CN1714092A Thieno[3,2-b]pyridine-6-carbonitriles and thieno[2,3-b]pyridine-5-carbonitriles as protein kinase inhibitors
12/28/2005CN1714084A Pyrimidine-2,4,6-trione metalloproteinase inhibitors
12/28/2005CN1713919A Novel use of erythropoietin in heart diseases
12/28/2005CN1233629C Sulfolipid compound with neural nourishing function and synthetic method and application thereof
12/28/2005CN1233613C Resveratrol oxo acid derivatives, their preparation and pharmaceutical compositions
12/28/2005CN1233421C Plasmid for gene therapy of cardiac muscle
12/28/2005CN1233415C CD26/DPP IV application in preparation of medicine for treating and/or diagnosing disease
12/28/2005CN1233414C Muscular amino acid and peptide nucleoside powder injection and its preparation method
12/28/2005CN1233405C Angitis treating medicine
12/28/2005CN1233396C External pile paste and its preparing method
12/28/2005CN1233372C Oral compound medicament with gingko leaf extractions for treating cardiovascular and cerebrovascular disease
12/28/2005CN1233369C Ginkgo leaf powder for injection and its preparation
12/28/2005CN1233361C Traditional Chinese medicine composition for treating cardiovascular disease
12/28/2005CN1233344C Externally applied piles-treating medicine
12/28/2005CN1233334C Oral liquid for detoxicating and dispelling wind
12/28/2005CN1233329C Hypotensor composition, prepn. method and application thereof
12/28/2005CN1233327C Highly effective sustained release breviscapine compositions and its granule capsule
12/28/2005CN1233324C Use of composition of intraocular pressure reducing agent
12/28/2005CN1233322C Method for producing xinnaoning injection containing chuanxiong rhizome and red sage root extract
12/28/2005CN1233320C Slow-releasing microball with nimoldipine and its preparing method
12/28/2005CN1233319C Indapamide slow release capsule and preparation method
12/28/2005CN1233314C Metoprolol dripping pills and the preparation process thereof
12/28/2005CN1233251C Tea capable of preventing and treating hypertension
12/27/2005US6979747 Antioxidants, preparation processes and their uses
12/27/2005US6979694 Drugs such as (5-(((2,4,6-Trimethylphenyl)amino)carbonyl)-4-methyl-2-thiazolyl)carbamic acid, 1,1-dimethylethyl ester, used as enzyme inhibitors, for prohylaxis of inflammatory bowel disease; modulation of immunology
12/27/2005US6979692 Triamide-substituted heterobicyclic compounds
12/27/2005US6979691 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
12/27/2005US6979690 Oxo or oxy-pyridine compounds as 5-HT4 receptor modulators
12/27/2005US6979683 Polymerase enzyme inhibitors
12/27/2005US6979677 Inhibition of vascular smooth muscle cell proliferation
12/27/2005US6979539 Regulation of endogenous gene expression in cells using zinc finger proteins
12/27/2005US6979532 Process for identifying substances which modulate the activity of hyperpolarization-activated cation channels
12/27/2005US6979447 Immunomodulation and effect on cell processes relating to serotonin family receptors
12/27/2005CA2290506C 4-bromo or 4-iodo phenylamino benzhydroxamic acid derivatives and their use as mek inhibitors
12/22/2005WO2005121149A1 Furanopyrimidine compounds effective as potassium channel inhibitors
12/22/2005WO2005120545A1 Compositions and methods for treatment of cardiovascular disease
12/22/2005WO2005120541A1 Process for producing protein having its antihypertensive activity enhanced
12/22/2005WO2005120534A1 Poncirus trifoliata extract for preventing and treating ischemic heart diseases and phar¬ maceutical composition and health food containing the same
12/22/2005WO2005120533A1 Polygala tenuifolia extract for preventing and treating ischemic heart disease and phar¬ maceutical composition and health food containing the same
12/22/2005WO2005120532A1 Nelumbinis semen extract for preventing and treating ischemic heart disease and pharmaceutical composition and health food containing the same
12/22/2005WO2005120531A1 Acorus gramineus soland extract for preventing and treating ischemic heart disease and pharmaceutical composition and health food containing the same
12/22/2005WO2005120518A2 Use of atp analogues for treatment of cardiovascular diseases
12/22/2005WO2005120485A1 Regulator of physiological function of ghrelin and use thereof
12/22/2005WO2005120484A1 Regulator for physiological functions of ghrelin
12/22/2005WO2005120481A1 Propafenone hydrochloride capsules containing microtablets
12/22/2005WO2005097814A3 Composition and method for inhibiting platelet aggregation
12/22/2005WO2005058231A3 Rifamycin analogs and uses thereof
12/22/2005WO2003057856A3 Dominant negative proteins and methods thereof
12/22/2005WO2002083874A3 Endothelial cell expression patterns
12/22/2005US20050283844 Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof
12/22/2005US20050282908 Substituted aminopropoxyaryl derivatives useful as agonists for LXR
12/22/2005US20050282889 Intracorporeal medicaments for photodynamic treatment of disease
12/22/2005US20050282885 Novel crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms
12/22/2005US20050282882 Diamines as modulators of chemokine receptor activity
12/22/2005US20050282881 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
12/22/2005US20050282876 Inhibitors of IMPDH enzyme
12/22/2005US20050282872 Novel thyroid receptor ligands and method II
12/22/2005US20050282867 Hydrochloride salt of 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazo-lidine-2,4-dione
12/22/2005US20050282866 2,3-Diphenyl-1H-indole-5-carboxylic acid; I kappa B kinase inhibitor; decrease activation of nuclear factor (NF) kappa B; antiinflammatory agent: arthritis, osteoarthritis, asthma, cardiac infarct, Alzheimer's disease, carcinomateous disorders or atherosclerosis
12/22/2005US20050282865 Neurotrophic factor production promoter
12/22/2005US20050282862 Aromatic amides
12/22/2005US20050282861 Sulfonamide-containing benzene derivatives; cancer and inflammatory, immunomodulatory or respiratory diseases; allergy, seasonal allergic rhinitis, reversible airway obstruction, adult respiratory distress syndrome, asthma, or bronchitis
12/22/2005US20050282843 Therapeutic applications of 2-substituted 4-heteroarylpyrimidines
12/22/2005US20050282838 Compounds, compositions, and methods
12/22/2005US20050282830 Use of dipyridamole or mopidamole for treatment and prevention of MMP-9-dependent disorders
12/22/2005US20050282817 4-(3-Phenyl-3-carbocycloylpropyl)-1-phenyl- or pyridylpiperazine derivatives: 1-(2-methoxyphenyl)-4-[3-(benzoyl)-3-(phenyl)propyl]piperazine oxalate; serotonin receptor antagonists; obesity
12/22/2005US20050282810 Oxindole derivatives
12/22/2005US20050282798 Pharmaceutical compounds
12/22/2005US20050282789 administering for treatment of metabolic bone diseases, mobilizing calcium for osteoporosis, imbalances in the immune system
12/22/2005US20050282786 Method for reducing c-rective protein levels with non-antibacterial tetracycline formulations
12/22/2005US20050282730 xanthocillin analogues such as 3,3'-Dimethoxyxanthocillin X dimethyl ether, used for increasing platelets in a human having a disease selected from thrombocytopenia caused by bone marrow grafting, surgery, infection, intestinal bleeding, anemia, myelodysplastic syndrome, and thrombopoietin deficiency
12/22/2005US20050282236 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
12/22/2005US20050282157 Using oligonucleotide and peptide nucleic acid oligomers for use as diagnostic tool in monitoring cytosine methylation; detecting cell proliferative, inflammatory, connective, bone, nervous system and cardiovascular disorders
12/22/2005US20050281897 Agent for preventing, improving or treating hypertension
12/22/2005US20050281818 Method for the treatment of fibrosis
12/22/2005US20050281794 comprising a catechin (epigallocatechin gallate), an anti-oxidant (ascorbic acid), proline and lysine; cancer
12/22/2005US20050281787 Tumor-specific vector for gene therapy
12/22/2005US20050279350 Methods and apparatus for relieving headaches, rhinitis and other common ailments
12/22/2005CA2573439A1 Compositions and methods for treating myocardial fibrosis comprising vasoactive intestinal peptide
12/22/2005CA2569678A1 Regulator of physiological function of ghrelin and use thereof
12/22/2005CA2568304A1 Furanopyrimidine compounds effective as potassium channel inhibitors
12/21/2005EP1607089A1 Monoesters of probucol for the treatment of cardiovascular and inflammatory disease
12/21/2005EP1607006A1 Functional berry composition
1 ... 735 736 737 738 739 740 741 742 743 744 745 746 747 748 749 750 751 752 753 754 755 ... 1595